Set to wind up in November
‘Fallen below our expectations’
Somerset GEM loses rating
Unilever has faced a tumultuous few weeks as news of its failed £50bn bid to buy GlaxoSmithKline’s consumer health unit came to light along with job cuts, scathing remarks from star fund managers and an activist investor taking a position.
Highlights strong performance of Fundsmith Equity fund
LGIM second for retail sales